The Nature of Leukotriene Inhibitor

Leukotriene Inhibitor is a type of prescription medication for the treatment of asthma and some allergies by blocking the formation of leukotrienes--the chemicals produced by the cells in the body. During asthma attacks or allergic reactions, leukotrienes and histamines are produced. These two substances are responsible for the symptoms and their consequent discomforts.  

As a drug for treating asthma, Leukotriene inhibitors decrease the symptoms to a moderate level in the lungs. This results to improve nighttime symptoms, and reduced number of asthma attacks.
Introduced in 1996, this relatively new drug represented the first new class of asthma medication in nearly 2 decades. Classified as an anti-inflammatory, leukotriene inhibitor was originally developed to help improve lung function during asthma attacks by making the smooth muscles around the bronchial airways to relax, and by reducing the inflammation.

 There are reported 50 million of cases of asthma and seasonal allergies in the United States alone. Given this very high number of people in the United States and the world suffering from all types of asthma attacks, this drug is a breakthrough in medicine in terms of effectiveness and affordability.  It also acts as a good alternative medicine for seasonal allergies. Leukotriene inhibitors are also known as modifiers, blockers, pathway modifiers, and antagonists.